RELATIONSHIP BETWEEN KNOWLEDGE OF DEGENERATIVE DISEASES AND PATIENTS’ MEDICATION ADHERENCE AT OTANAHA REGIONAL GENERAL HOSPITAL (RSUD OTANAHA)
DOI:
https://doi.org/10.47918/6v51mt86Keywords:
degenerative diseases; knowledge; medication adherence; diabetes mellitus; hypertension.Abstract
Degenerative diseases such as diabetes mellitus and hypertension require long-term pharmacological treatment and consistent medication adherence to prevent complications and maintain patients’ health. Patient knowledge regarding disease characteristics, treatment objectives, medication use, and potential complications may influence adherence behavior. This study aimed to determine the relationship between knowledge of degenerative diseases and medication adherence among patients with diabetes mellitus and hypertension at Otanaha Regional General Hospital. This study employed a quantitative analytical approach with a cross-sectional design. The study population consisted of 52 patients, with 46 respondents selected using the Slovin formula, comprising 23 patients with diabetes mellitus and 23 patients with hypertension. Data were collected using a structured knowledge questionnaire and the 8-item Morisky Medication Adherence Scale (MMAS-8). Data were analyzed using frequency distributions and Pearson correlation with a significance level of 0.05. Among patients with diabetes mellitus, moderate medication adherence was the most common category (43.48%), while good and moderate knowledge each accounted for 30.43%. A significant positive relationship was found between knowledge and medication adherence (p=0.047; r=0.315). Among patients with hypertension, the largest proportion was categorized as adherent (34.78%), while very good knowledge was most prevalent (30.43%). A significant and very strong positive relationship was observed (p=0.004; r=0.878). These findings indicate that better disease knowledge is associated with higher medication adherence, although the strength of the relationship differs between disease groups.
Downloads
References
[1] N. Afiani and I. Nurmala, “A systematic review on the determinants of medication adherence in older adults with hypertension,” J. Public Health Africa, vol. 14, no. S2, 2023, doi: 10.4081/jphia.2023.2578.
[2] H. Al-Noumani, M. Al-Harrasi, J. Jose, Z. Al-Naamani, and S. M. Panchatcharam, “Medication Adherence and Patients’ Characteristics in Chronic Diseases: A National Multi-Center Study,” Clin. Nurs. Res., vol. 31, no. 3, pp. 426–434, 2022, doi: 10.1177/10547738211033754.
[3] A. M. Peterson, “Medication Adherence in Primary Care,” in Handbook of Evidence-Based Prevention of Behavioral Disorders in Integrated Care: A Stepped Care Approach, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, PA, United States: Springer International Publishing, 2021, pp. 327–340. doi: 10.1007/978-3-030-83469-2_14.
[4] D. Sharma, N. K. Goel, Y. S. Cheema, and K. Garg, “Medication Adherence and its Predictors among Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study,” Indian J. Community Med., vol. 48, no. 5, pp. 781–785, 2023, doi: 10.4103/ijcm.ijcm_744_22.
[5] D. M. AlShayban et al., “Association of Disease Knowledge and Medication Adherence Among Out-Patients With Type 2 Diabetes Mellitus in Khobar, Saudi Arabia,” Front. Pharmacol., vol. 11, 2020, doi: 10.3389/fphar.2020.00060.
[6] G. B. Mekonnen and D. A. Gelayee, “Low Medication Knowledge and Adherence to Oral Chronic Medications among Patients Attending Community Pharmacies: A Cross-Sectional Study in a Low-Income Country,” Biomed Res. Int., vol. 2020, 2020, doi: 10.1155/2020/4392058.
[7] M. Kelly, S. McCarthy, and L. J. Sahm, “Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: A review of qualitative literature,” Eur. J. Clin. Pharmacol., vol. 70, no. 12, pp. 1423–1431, 2014, doi: 10.1007/s00228-014-1761-3.
[8] Y.-X. Ni, L.-L. Liu, H. Feng, Z. Li, C.-Y. Qin, and M. Chen, “Adherence, belief, and knowledge about oral anticoagulants in patients with bioprosthetic heart valve replacement: a cross-sectional study,” Front. Pharmacol., vol. 14, 2023, doi: 10.3389/fphar.2023.1191006.
[9] D. Selvakumar, P. Sivanandy, P. V Ingle, and K. Theivasigamani, “Relationship between Treatment Burden, Health Literacy, and Medication Adherence in Older Adults Coping with Multiple Chronic Conditions,” Med., vol. 59, no. 8, 2023, doi: 10.3390/medicina59081401.
[10] A. A. Alsaidan et al., “Medication Adherence and Its Associated Factors among Patients with Type 2 Diabetes Mellitus Attending Primary Health Centers of Eastern Province, Saudi Arabia,” Med., vol. 59, no. 5, 2023, doi: 10.3390/medicina59050989.
[11] E. Costa et al., “Interventional tools to improve medication adherence: Review of literature,” Patient Prefer. Adherence, vol. 9, pp. 1303–1314, 2015, doi: 10.2147/PPA.S87551.
[12] H. Al-Noumani, M. Alharrasi, E. R. Lazarus, and S. M. Panchatcharam, “Factors predicting medication adherence among Omani patients with chronic diseases through a multicenter cross-sectional study,” Sci. Rep., vol. 13, no. 1, 2023, doi: 10.1038/s41598-023-34393-4.
[13] S. Patel, M. Huang, and S. Miliara, “Understanding Treatment Adherence in Chronic Diseases: Challenges, Consequences, and Strategies for Improvement,” J. Clin. Med., vol. 14, no. 17, 2025, doi: 10.3390/jcm14176034.
[14] P. Schnorrerova, P. Matalova, and M. Wawruch, “Medication Adherence and Intervention Strategies: Why Should We Care,” Bratislava Med. J., vol. 126, no. 7, pp. 1196–1206, 2025, doi: 10.1007/s44411-025-00227-0.
[15] F. Islahudin and S. Z. Hasan, “Medication adherence and satisfaction among patients in Malaysia,” Res. J. Pharm. Technol., vol. 12, no. 3, pp. 1051–1054, 2019, doi: 10.5958/0974-360X.2019.00173.2.
[16] N. Chanane, F. Mirza, M. A. Naeem, and A. Mirza, “Acceptance of technology-driven interventions for improving medication adherence,” in Communications in Computer and Information Science, P. S., D. R., and Z. W., Eds., Department of Information Technology and Software Engineering, Auckland University of Technology, Auckland, New Zealand: Springer Verlag, 2017, pp. 188–198. doi: 10.1007/978-3-319-65548-2_15.
[17] C. E. Hartch, M. S. Dietrich, B. J. Lancaster, D. P. Stolldorf, and S. A. Mulvaney, “Effects of a medication adherence app among medically underserved adults with chronic illness: a randomized controlled trial,” J. Behav. Med., vol. 47, no. 3, pp. 389–404, 2024, doi: 10.1007/s10865-023-00446-2.
[18] S. Hyvert et al., “Association between health literacy and medication adherence in chronic diseases: a recent systematic review,” Int. J. Clin. Pharm., vol. 45, no. 1, pp. 38–51, 2023, doi: 10.1007/s11096-022-01470-z.
[19] A. Q. Al Bawab, W. Al-Qerem, O. Abusara, N. Alkhatib, M. Mansour, and R. Horne, “What are the factors associated with nonadherence to medications in patients with chronic diseases?,” Healthc., vol. 9, no. 9, 2021, doi: 10.3390/healthcare9091237.
